Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus
Year: 2016
Type: review
Source: Postgraduate Medicine
Authors: Thomas C. Blevins, Azeez Farooki
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Janssen Research and Development
OpenAlex ID: W2558297083
